|
À¯·´ÀÇ ¿©¼º¿ë ÀڱðæºÎ ºÒÀÓ ÀåÄ¡ ½ÃÀå
European Market Report for Transcervical Female Sterilization 2016 - MedCore
|
¸®¼Ä¡»ç |
iData Research Inc.
|
¹ßÇàÀÏ |
2016³â 09¿ù |
»óǰ ÄÚµå |
478134 |
ÆäÀÌÁö Á¤º¸ |
¿µ¹® 62 Pages |
°¡°Ý |
|
À¯·´ÀÇ ¿©¼º¿ë ÀڱðæºÎ ºÒÀÓ ÀåÄ¡ ½ÃÀå
European Market Report for Transcervical Female Sterilization 2016 - MedCore
|
¹ßÇàÀÏ : 2016³â 09¿ù | ÆäÀÌÁö Á¤º¸ : ¿µ¹® 62 Pages |
|
|
¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹®¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹®¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
À¯·´ÀÇ ¿©¼º¿ë ÀڱðæºÎ ºÒÀÓ ÀåÄ¡(Transcervical Female Sterilization) ½ÃÀå¿¡ ´ëÇØ ºÐ¼®ÇßÀ¸¸ç, Á¦Ç° °³¿ä, ½ÃÀå ±Ô¸ð ½ÇÀû°ú ¿¹Ãø(°ú°Å 4³â°£, ÇâÈÄ 7³â°£), Á¦Ç°º° µ¿Çâ, ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¡¤¾ïÁ¦¿äÀÎ, ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À², °¢±¹ ½ÃÀåÀÇ ½ÃÀå ±¸Á¶ µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.
ÁÖ¿ä ¿ä¾à
À¯·´ÀÇ ºÎÀΰú¿ë ÀÇ·á±â±â ½ÃÀå : °³¿ä
°æÀï ºÐ¼®
½ÃÀå µ¿Çâ
½ÃÀå ¹ßÀü
½Ã¼ú °Ç¼ö
ºÐ¼® ´ë»ó ½ÃÀå
ÁÖ¿ä ºÐ¼® ¾÷µ¥ÀÌÆ®
°ú°Å ¹öÀü
Á¦1Àå ºÐ¼® ¹æ¹ý
- ºÐ¼® ¹üÀ§
- IDATAÀÇ 9 ´Ü°è ºÐ¼® ¹æ¹ý
Á¦2Àå ±¹°¡º° ½ÃÀå °³¿ä
- ¼·Ð
- ÃÑÀα¸
- Æò±Õ ¿¬·É
- 1Àδç GDP
- ¹°°¡ Áö¼ö
- µ¶ÀÏ
- ÇÁ¶û½º
- ¿µ±¹
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- º£³×·è½º ±¹°¡
- ºÏÀ¯·´ ±¹°¡
- ¿À½ºÆ®¸®¾Æ
- ½ºÀ§½º
- Æ÷¸£Åõ°¥
Á¦3Àå ¿©¼º¿ë ÀڱðæºÎ ºÒÀÓ ÀåÄ¡ ½ÃÀå
- ¼·Ð
- ³°ü°áÂû¼ú(Tubal Ligation)
- ±â°èÀû ÇÇÀÓ
- ½Ö±Ø Àü±âÀÀ°í(Bipolar Electrocoagulation)
- ÀڱðæºÎ ÀÓÇöõÆ®(Transcervical Implant)
- ½ÃÀå ºÐ¼®°ú ¿¹Ãø
- ½ÃÀå ¼ºÀå ÃËÁø¡¤¾ïÁ¦¿äÀÎ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
- ±â¾÷º° ½ÃÀå Á¡À¯À² ºÐ¼®
¾à¾î
µµÇ¥
KSM 17.04.06
Female sterilization is a permanent form of birth control, requiring invasive surgery to reverse. Female sterilization prevents ova from coming down the fallopian tubes and blocks fertilization by sperm. There are different procedures to perform female sterilization, including tubal ligation, mechanical blockage with a clip or band, bipolar electrocoagulation or transcervical implants. In this report, only the transcervical implant market is covered.
The transcervical implant market in Europe currently consists of Bayer AG as the sole competitor offering the Essure® product. Essure® was first developed by the company Conceptus in 2001 and was certified for sale throughout Europe, with the first sale occurring in October 2002. In the United States, Essure® was subsequently approved by the FDA on November 4th, 2002. In April 2013, Bayer AG acquired Conceptus to offer Essure® as part of their contraceptive portfolio. In the United Kingdom, the National Institute for Health and Care Excellence approved Essure® in 2009, the last European country to do so. Since Essure® entered the market in 2002, other notable competitors have been the Ovabloc System and the Adiana procedure. Both of these procedures have since been discontinued.
TABLE OF CONTENTS
TABLE OF CONTENTS
LIST OF FIGURES
LIST OF CHARTS
EXECUTIVE SUMMARY
EUROPEAN MARKET FOR GYNECOLOGICAL DEVICES OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
- 1.1. RESEARCH SCOPE
- 1.2. IDATA'S 9-STEP METHODOLOGY
- 1.2.1. Step 1: Project Initiation & Team Selection
- 1.2.2. Step 2: Prepare Data Systems and Perform Secondary Research
- 1.2.3. Step 3: Preparation for Interviews & Questionnaire Design
- 1.2.4. Step 4: Performing Primary Research
- 1.2.5. Step 5: Research Analysis: Establishing Baseline Estimates
- 1.2.6. Step 6: Market Forecast and Analysis
- 1.2.7. Step 7: Identify Strategic Opportunities
- 1.2.8. Step 8: Final Review and Market Release
- 1.2.9. Step 9: Customer Feedback and Market Monitoring
COUNTRY PROFILES
- 2.1. INTRODUCTION
- 2.1.1.1. Population
- 2.1.1.2. Median Age
- 2.1.1.3. GDP Per Capita
- 2.1.1.4. Price Index
- 2.2. GERMANY
- 2.3. FRANCE
- 2.4. UNITED KINGDOM
- 2.5. ITALY
- 2.6. SPAIN
- 2.7. BENELUX
- 2.8. SCANDINAVIA
- 2.9. AUSTRIA
- 2.10. SWITZERLAND
- 2.11. PORTUGAL
TRANSCERVICAL FEMALE STERILIZATION MARKET
- 3.1. INTRODUCTION
- 3.1.1. Tubal Ligation
- 3.1.2. Mechanical Sterilization
- 3.1.3. Bipolar Electrocoagulation
- 3.1.4. Transcervical Implant
- 3.2. MARKET ANALYSIS AND FORECAST
- 3.3. DRIVERS AND LIMITERS
- 3.3.1. Market Drivers
- 3.3.2. Market Limiters
- 3.4. COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
LIST OF CHARTS
- Chart 1-1: Gynecological Device Market by Segment, Europe, 2012 - 2022
- Chart 1-2: Gynecological Device Market Overview, Europe, 2015 & 2022
- Chart 2-1: Country Profile, Germany, 2015
- Chart 2-2: Country Profile, France, 2015
- Chart 2-3: Country Profile, United Kingdom, 2015
- Chart 2-4: Country Profile, Italy, 2015
- Chart 2-5: Country Profile, Spain, 2015
- Chart 2-6: Country Profile, Benelux, 2015
- Chart 2-7: Country Profile, Scandinavia, 2015
- Chart 2-8: Country Profile, Austria, 2015
- Chart 2-9: Country Profile, Switzerland, 2015
- Chart 2-10: Country Profile, Portugal, 2015
- Chart 3-1: Transcervical Female Sterilization Market, Europe, 2012 - 2022
- Chart 3-2: Leading Competitors, Transcervical Female Sterilization Market, Europe, 2015
LIST OF FIGURES
- Figure 1-1: Gynecological Device Competitor Market Share Ranking by Segment, Europe, 2015 (1 of 3)
- Figure 1-2: Gynecological Device Competitor Market Share Ranking by Segment, Europe, 2015 (2 of 3)
- Figure 1-3: Gynecological Device Competitor Market Share Ranking by Segment, Europe, 2015 (3 of 3)
- Figure 1-4: Companies Researched in this Report, Europe, 2015
- Figure 1-5: Factors Impacting the Gynecological Device Market by Segment, Europe (1 of 3)
- Figure 1-6: Factors Impacting the Gynecological Device Market by Segment, Europe (2 of 3)
- Figure 1-7: Factors Impacting the Gynecological Device Market by Segment, Europe (3 of 3)
- Figure 1-8: Recent Events in Gynecological Device Market, Europe, 2012 - 2016
- Figure 1-9: Gynecological Procedures Covered, Europe, 2015
- Figure 1-10: Gynecological Device Markets Covered, Europe, 2015 (1 of 2)
- Figure 1-11: Gynecological Device Markets Covered, Europe, 2015 (2 of 2)
- Figure 1-12: Key Report Updates (1 of 3)
- Figure 1-13: Key Report Updates (2 of 3)
- Figure 1-14: Key Report Updates (3 of 3)
- Figure 1-15: Version History
- Figure 2-1: Population by Country, Europe, 2015
- Figure 2-2: Population, Benelux, 2015
- Figure 2-3: Scandinavia, Europe, 2015
- Figure 2-4: GDP per Capita, Europe, 2015
- Figure 3-1: Transcervical Female Sterilization Market, Europe, 2012 - 2022 (€ and US$)
- Figure 3-2: Units Sold by Country, Transcervical Female Sterilization Market, Europe, 2012-2022
- Figure 3-3: Average Sales Price by Country, Transcervical Female Sterilization Market, Europe, 2012-2022 (€)
- Figure 3-4: Average Sales Price by Country, Transcervical Female Sterilization Market, Europe, 2012-2022 (US$)
- Figure 3-5: Transcervical Female Sterilization Market by Country, Europe, 2012-2022 (€M)
- Figure 3-6: Transcervical Female Sterilization Market by Country, Europe, 2012-2022 (US$M)
- Figure 3-7: Drivers and Limiters, Transcervical Female Sterilization Market, Europe, 2015
- Figure 3-8: Leading Competitors by Country, Transcervical Female Sterilization Market, Europe, 2015
|

|
|